Extensive validation study of the Parkinson's Disease Composite Scale

the PDCS European Study Group

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and purpose: A composite instrument able to rapidly and reliably assess the most relevant motor and non-motor afflictions suffered by Parkinson's disease (PD) patients in a real world clinic setting is an unmet need. The recently validated PD Composite Scale (PDCS) was designed to fulfil this gap as a quick, comprehensive PD assessment. The objective of this study was extensive evaluation of the PDCS's clinimetric properties using a large international sample. Methods: This was a cross-sectional study in which the PDCS, the Movement Disorder Society Unified Parkinson's Disease Rating Scale and the Clinical Impression of Severity Index for PD were applied. Basic clinimetric attributes of the PDCS were analysed. Results: In total, 776 PD patients were included. The PDCS total score showed negligible floor and ceiling effects. Three factors (54.5% of the variance) were identified: factor 1 included motor impairment, fluctuations and disability; factor 2, non-motor symptoms; and factor 3, tremor and complications of therapy. Cronbach's alpha was from 0.66 to 0.79. Inter-rater reliability showed weighted kappa values from 0.79 to 0.98 for items and intraclass correlation coefficient values from 0.95 (Disability) to 0.99 (Motor and total score). The Bland–Altmann method, however, showed irregular concordance. PDCS standard error of measurement and convergent validity with equivalent constructs of other measures were satisfactory (≥0.70). PDCS scores significantly differed by Hoehn and Yahr stage. Conclusion: Overall, in line with previous findings, the PDCS is a feasible, acceptable, valid, reliable and precise instrument for quickly and comprehensively assessing PD patients.

Original languageEnglish
JournalEuropean Journal of Neurology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Validation Studies
Parkinson Disease
Tremor
Cross-Sectional Studies

Keywords

  • dimensionality
  • inter-rater reliability
  • Parkinson's disease
  • Parkinson's Disease Composite Scale
  • validation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Extensive validation study of the Parkinson's Disease Composite Scale. / the PDCS European Study Group.

In: European Journal of Neurology, 01.01.2019.

Research output: Contribution to journalArticle

@article{3d2e89b3ed734aefb14974715e267464,
title = "Extensive validation study of the Parkinson's Disease Composite Scale",
abstract = "Background and purpose: A composite instrument able to rapidly and reliably assess the most relevant motor and non-motor afflictions suffered by Parkinson's disease (PD) patients in a real world clinic setting is an unmet need. The recently validated PD Composite Scale (PDCS) was designed to fulfil this gap as a quick, comprehensive PD assessment. The objective of this study was extensive evaluation of the PDCS's clinimetric properties using a large international sample. Methods: This was a cross-sectional study in which the PDCS, the Movement Disorder Society Unified Parkinson's Disease Rating Scale and the Clinical Impression of Severity Index for PD were applied. Basic clinimetric attributes of the PDCS were analysed. Results: In total, 776 PD patients were included. The PDCS total score showed negligible floor and ceiling effects. Three factors (54.5{\%} of the variance) were identified: factor 1 included motor impairment, fluctuations and disability; factor 2, non-motor symptoms; and factor 3, tremor and complications of therapy. Cronbach's alpha was from 0.66 to 0.79. Inter-rater reliability showed weighted kappa values from 0.79 to 0.98 for items and intraclass correlation coefficient values from 0.95 (Disability) to 0.99 (Motor and total score). The Bland–Altmann method, however, showed irregular concordance. PDCS standard error of measurement and convergent validity with equivalent constructs of other measures were satisfactory (≥0.70). PDCS scores significantly differed by Hoehn and Yahr stage. Conclusion: Overall, in line with previous findings, the PDCS is a feasible, acceptable, valid, reliable and precise instrument for quickly and comprehensively assessing PD patients.",
keywords = "dimensionality, inter-rater reliability, Parkinson's disease, Parkinson's Disease Composite Scale, validation",
author = "{the PDCS European Study Group} and P. Martinez-Martin and Radicati, {F. G.} and {Rodriguez Blazquez}, C. and J. Wetmore and N. Kov{\'a}cs and {Ray Chaudhuri}, K. and F. Stocchi",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ene.13976",
language = "English",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Extensive validation study of the Parkinson's Disease Composite Scale

AU - the PDCS European Study Group

AU - Martinez-Martin, P.

AU - Radicati, F. G.

AU - Rodriguez Blazquez, C.

AU - Wetmore, J.

AU - Kovács, N.

AU - Ray Chaudhuri, K.

AU - Stocchi, F.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background and purpose: A composite instrument able to rapidly and reliably assess the most relevant motor and non-motor afflictions suffered by Parkinson's disease (PD) patients in a real world clinic setting is an unmet need. The recently validated PD Composite Scale (PDCS) was designed to fulfil this gap as a quick, comprehensive PD assessment. The objective of this study was extensive evaluation of the PDCS's clinimetric properties using a large international sample. Methods: This was a cross-sectional study in which the PDCS, the Movement Disorder Society Unified Parkinson's Disease Rating Scale and the Clinical Impression of Severity Index for PD were applied. Basic clinimetric attributes of the PDCS were analysed. Results: In total, 776 PD patients were included. The PDCS total score showed negligible floor and ceiling effects. Three factors (54.5% of the variance) were identified: factor 1 included motor impairment, fluctuations and disability; factor 2, non-motor symptoms; and factor 3, tremor and complications of therapy. Cronbach's alpha was from 0.66 to 0.79. Inter-rater reliability showed weighted kappa values from 0.79 to 0.98 for items and intraclass correlation coefficient values from 0.95 (Disability) to 0.99 (Motor and total score). The Bland–Altmann method, however, showed irregular concordance. PDCS standard error of measurement and convergent validity with equivalent constructs of other measures were satisfactory (≥0.70). PDCS scores significantly differed by Hoehn and Yahr stage. Conclusion: Overall, in line with previous findings, the PDCS is a feasible, acceptable, valid, reliable and precise instrument for quickly and comprehensively assessing PD patients.

AB - Background and purpose: A composite instrument able to rapidly and reliably assess the most relevant motor and non-motor afflictions suffered by Parkinson's disease (PD) patients in a real world clinic setting is an unmet need. The recently validated PD Composite Scale (PDCS) was designed to fulfil this gap as a quick, comprehensive PD assessment. The objective of this study was extensive evaluation of the PDCS's clinimetric properties using a large international sample. Methods: This was a cross-sectional study in which the PDCS, the Movement Disorder Society Unified Parkinson's Disease Rating Scale and the Clinical Impression of Severity Index for PD were applied. Basic clinimetric attributes of the PDCS were analysed. Results: In total, 776 PD patients were included. The PDCS total score showed negligible floor and ceiling effects. Three factors (54.5% of the variance) were identified: factor 1 included motor impairment, fluctuations and disability; factor 2, non-motor symptoms; and factor 3, tremor and complications of therapy. Cronbach's alpha was from 0.66 to 0.79. Inter-rater reliability showed weighted kappa values from 0.79 to 0.98 for items and intraclass correlation coefficient values from 0.95 (Disability) to 0.99 (Motor and total score). The Bland–Altmann method, however, showed irregular concordance. PDCS standard error of measurement and convergent validity with equivalent constructs of other measures were satisfactory (≥0.70). PDCS scores significantly differed by Hoehn and Yahr stage. Conclusion: Overall, in line with previous findings, the PDCS is a feasible, acceptable, valid, reliable and precise instrument for quickly and comprehensively assessing PD patients.

KW - dimensionality

KW - inter-rater reliability

KW - Parkinson's disease

KW - Parkinson's Disease Composite Scale

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=85066631658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066631658&partnerID=8YFLogxK

U2 - 10.1111/ene.13976

DO - 10.1111/ene.13976

M3 - Article

C2 - 31021043

AN - SCOPUS:85066631658

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

ER -